Healthy Volunteers Needed for New Autotaxin-Inhibitor Study

We are testing a new drug, MJK2134025, to see how it affects healthy individuals. This study will help us understand its safety and how different doses work.

Safety phase (I)AllergologyCardiologyDermatologyDiabetologyEndocrinologyGastroenterologyGynecology and ObstetricsHematologyInfectious DiseasesInternal MedicineNeurologyOncologyOrthopedics and TraumatologyPediatricsPsychiatryPulmonologyRheumatologyUrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Department of Neurology
Mainz, Germany
Sponsor: Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.